Favier Remi, De Carne Celine, Elefant Elisabeth, Lapusneanu Ruxanda, Gkalea Vasiliki, Rigouzzo Agnès
From the Assistance Publique-Hôpitaux de Paris, Paris, France; French Reference Centre for Inherited Platelet Disorders, A Trousseau Children Hospital, Paris, France; Department of Obstetrics and Gynecology and French Reference Centre for Teratogenic Agents, A Trousseau Children Hospital, Paris, France; Haematological Laboratory, Tenon Hospital, Paris, France; and Department of Anesthesiology, A Trousseau Children Hospital, Paris, France.
A A Pract. 2018 Jan 1;10(1):10-12. doi: 10.1213/XAA.0000000000000621.
MYH9-related disease (MYH9-RD) is an inherited rare autosomal dominant macrothrombocytopenia. Patients with MYH9-RD have giant platelets and leukocyte inclusion bodies caused by mutations in the MYH9 gene encoding the non-muscle myosin heavy chain II-A. Before identification of the causative gene, patients were diagnosed as Epstein or Fechtner or Sebastian syndromes or May-Hegglin anomaly. As with other inherited thrombocytopenias, the risk of increased bleeding during perioperative period or delivery is a major concern. We report here the first successful cesarean delivery of a woman with MYH9-RD treated with eltrombopag during the last month of pregnancy.
Platelets. 2017-11-1
Drug News Perspect. 2008
Haematologica. 2022-6-1
Case Rep Obstet Gynecol. 2022-2-25
Int J Mol Sci. 2021-4-21
Ther Adv Hematol. 2021-3-19